Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma
Clinical trial NCT03262389 · COMPLETED
Trial details
- NCT number
- NCT03262389
- Sponsor
- Michael C Roarke, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2019-11-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.